These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20553388

  • 41. The prediction role of D-dimer in recurrence of venous thromboembolism 1-year after anticoagulation discontinuing following idiopathic deep vein thrombosis.
    Tamizifar B, Oghab P, Esfahani MA.
    J Res Med Sci; 2014 Jul; 19(7):586-91. PubMed ID: 25364355
    [Abstract] [Full Text] [Related]

  • 42. Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence.
    Legnani C, Cini M, Cosmi B, Carraro P, Tripodi A, Erba N, Palareti G.
    Intern Emerg Med; 2013 Apr; 8(3):229-36. PubMed ID: 21584847
    [Abstract] [Full Text] [Related]

  • 43. Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors.
    Palareti G.
    Expert Rev Hematol; 2017 Oct; 10(10):921-931. PubMed ID: 28803491
    [Abstract] [Full Text] [Related]

  • 44. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
    Zabczyk M, Plens K, Wojtowicz W, Undas A.
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
    [Abstract] [Full Text] [Related]

  • 45. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study.
    Legnani C, Palareti G, Cosmi B, Cini M, Tosetto A, Tripodi A, PROLONG Investigators (FCSA and Italian Federation of Thrombosis Centers).
    Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269
    [Abstract] [Full Text] [Related]

  • 46. Factor XI and recurrent venous thrombosis: an observational cohort study.
    Kyrle PA, Eischer L, Šinkovec H, Eichinger S.
    J Thromb Haemost; 2019 May; 17(5):782-786. PubMed ID: 30784172
    [Abstract] [Full Text] [Related]

  • 47. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.
    Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M, Kyrle P, Poli D, Tait RC, Iorio A.
    BMJ; 2011 Feb 24; 342():d813. PubMed ID: 21349898
    [Abstract] [Full Text] [Related]

  • 48. Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review.
    Chopard R, Albertsen IE, Piazza G.
    JAMA; 2020 Nov 03; 324(17):1765-1776. PubMed ID: 33141212
    [Abstract] [Full Text] [Related]

  • 49. A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
    Aranda C, Peralta L, Gagliardi L, López A, Jiménez Á, Herreros B.
    Thromb Res; 2021 Jun 03; 202():31-35. PubMed ID: 33711756
    [Abstract] [Full Text] [Related]

  • 50. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis.
    Jara-Palomares L, Solier-Lopez A, Elias-Hernandez T, Asensio-Cruz MI, Blasco-Esquivias I, Sanchez-Lopez V, de la Borbolla MR, Arellano-Orden E, Suarez-Valdivia L, Marin-Romero S, Marin-Barrera L, Ruiz-Garcia A, Montero-Romero E, Navarro-Herrero S, Lopez-Campos JL, Serrano-Gotarredona MP, Praena-Fernandez JM, Sanchez-Diaz JM, Otero-Candelera R.
    Br J Cancer; 2018 Oct 03; 119(8):915-921. PubMed ID: 30318508
    [Abstract] [Full Text] [Related]

  • 51. The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism.
    Prandoni P.
    Adv Exp Med Biol; 2017 Oct 03; 906():89-100. PubMed ID: 27620306
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial.
    Cohen AT, Spiro TE, Spyropoulos AC, Desanctis YH, Homering M, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Tapson VF, Burton P, MAGELLAN Study Group.
    J Thromb Haemost; 2014 Apr 03; 12(4):479-87. PubMed ID: 24460645
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
    Franco Moreno AI, García Navarro MJ, Ortiz Sánchez J, Martín Díaz RM, Madroñal Cerezo E, de Ancos Aracil CL, Cabello Clotet N, Perales Fraile I, Gimeno García S, Montero Hernández C, Zapatero Gaviria A, Ruiz Giardín JM.
    Eur J Intern Med; 2016 Apr 03; 29():59-64. PubMed ID: 26775136
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.